Petgo Corporation (7140) Stock Price

PetGo operates primarily in the pet healthcare business segment. The company's mission is to maximize pets' healthy lifespans and improve their quality of life. PetGo leverages technology to run an e-commerce platform specialized in pet healthcare.

PetGo sells pet healthcare products including veterinary pharmaceuticals, therapeutic pet foods, and supplements. These products were traditionally available only through veterinary clinics, but PetGo's online sales model reduces the burden on pet owners and contributes to improving pets' quality of life.

PetGo sells pet healthcare products through its own online site "petgo" and third-party online marketplaces. Key products include veterinary pharmaceuticals such as flea and tick prevention treatments, eye drops, skin medications, and gastrointestinal medications, as well as therapeutic pet foods for specific conditions and supplements.

PetGo's business is characterized by three features: "D2C brands," "multi-channel distribution," and "subscription commerce." As a D2C brand, the company operates the "VetsOne" product line, offering therapeutic pet foods, complete nutritional foods, and flea and tick prevention treatments.

Through multi-channel distribution, PetGo expands its customer base and accumulates pet data. This enables the company to accurately understand customer needs and apply insights to D2C brand product development. The company also offers subscription services to enhance customer convenience.

PetGo's strengths are its vast collection of high-value pet data and a digitalized DX platform that automates most business operations. These capabilities enable the company to enhance customer convenience, satisfaction, and trust in marketing and product planning.

PetGo aims to maximize pets' healthy lifespan and improve their quality of life. The company operates e-commerce specialized in pet healthcare using technology, providing products that support pet health.

As its medium-term growth strategy, PetGo has adopted a "D2C Shift." This strategy involves transitioning from national brands to direct-to-consumer (D2C) brands to achieve stable product supply and higher profit margins. By the fiscal year ending March 2025, the company increased the D2C brand sales ratio to 21%.

PetGo's growth strategy is based on three pillars: product, channel, and promotion. The company accelerates D2C brand growth through new product development, channel expansion across online and offline platforms, and promotional activities leveraging social media.

The company uses revenue, operating profit, and D2C brand sales as key performance indicators, targeting sustained growth. Against the backdrop of an expanding pet market, PetGo is expanding its pet healthcare product portfolio and contributing to improved pet quality of life.

PetGo is addressing priority challenges including strengthening D2C brand product development, increasing awareness of its proprietary online site, and enhancing its DX platform. Through these efforts, the company aims to strengthen competitiveness and achieve sustainable growth.